Lion Street Advisors LLC Purchases 480 Shares of The Clorox Company (NYSE:CLX)

Lion Street Advisors LLC grew its holdings in The Clorox Company (NYSE:CLX) by 10.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,294 shares of the company’s stock after purchasing an additional 480 shares during the quarter. Lion Street Advisors LLC’s holdings in Clorox were worth $860,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in CLX. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Clorox by 21.3% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 18,508 shares of the company’s stock valued at $3,013,000 after buying an additional 3,249 shares during the period. Verity Asset Management Inc. raised its holdings in Clorox by 8.4% in the 4th quarter. Verity Asset Management Inc. now owns 3,110 shares of the company’s stock valued at $501,000 after acquiring an additional 241 shares in the last quarter. Boston Trust Walden Corp lifted its position in shares of Clorox by 4.0% in the 4th quarter. Boston Trust Walden Corp now owns 284,821 shares of the company’s stock worth $46,258,000 after acquiring an additional 10,913 shares during the period. HHM Wealth Advisors LLC grew its holdings in shares of Clorox by 212.1% during the 4th quarter. HHM Wealth Advisors LLC now owns 2,216 shares of the company’s stock worth $360,000 after purchasing an additional 1,506 shares in the last quarter. Finally, Willis Investment Counsel increased its position in shares of Clorox by 0.4% during the fourth quarter. Willis Investment Counsel now owns 185,785 shares of the company’s stock valued at $30,173,000 after purchasing an additional 819 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

Clorox stock opened at $148.29 on Wednesday. The company has a market cap of $18.36 billion, a PE ratio of 51.67, a PEG ratio of 2.92 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company’s 50-day moving average is $162.63 and its two-hundred day moving average is $158.67.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period last year, the company earned $2.16 EPS. Equities analysts anticipate that The Clorox Company will post 6.86 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.29%. Clorox’s dividend payout ratio is presently 170.04%.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of recent research reports. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. JPMorgan Chase & Co. upped their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday. Finally, Evercore ISI raised their target price on Clorox from $145.00 to $155.00 in a research report on Tuesday. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $157.50.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.